Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An olfactory neuroblastoma arising in the nasal cavity.
Biomarker and diagnostic research for nasal cavity olfactory neuroblastoma has been reported in the published literature.
No clinical trials have been registered for nasal cavity olfactory neuroblastoma.
67 publications have been identified in PubMed for nasal cavity olfactory neuroblastoma. Research spans Review / Meta-Analysis (24%), Case Report / Case Series (24%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 16 | 24% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 1:39 AM UTC
Patient case studies
16 |
24% |
Clinical study results | 11 | 16% |
Disease patterns and progression | 8 | 12% |
Testing and diagnosis research | 7 | 10% |
Laboratory research | 6 | 9% |
New treatment approaches | 2 | 3% |
Other research | 1 | 1% |
Wu L (2026). [PMID: 41628435](https://pubmed.ncbi.nlm.nih.gov/41628435/). *J Neurosurg Case Lessons*. [Case Report / Case Series]
Sekimizu M (2026). [PMID: 41449573](https://pubmed.ncbi.nlm.nih.gov/41449573/). *Jpn J Clin Oncol*. [Diagnostic / Biomarker]
Limaiem F (2026). [PMID: 30969516](https://pubmed.ncbi.nlm.nih.gov/30969516/). *Unknown Journal*. [Other]
Nishida A (2026). [PMID: 42203325](https://pubmed.ncbi.nlm.nih.gov/42203325/). *Anticancer Res*. [Clinical Trial Publication]
Jauhiainen MK (2026). [PMID: 41874350](https://pubmed.ncbi.nlm.nih.gov/41874350/). *Neuropathology*. [Basic Science / Preclinical]
He K (2026). [PMID: 41904722](https://pubmed.ncbi.nlm.nih.gov/41904722/). *Discov Oncol*. [Case Report / Case Series]
Hsia B (2026). [PMID: 42095028](https://pubmed.ncbi.nlm.nih.gov/42095028/). *J Neurol Surg B Skull Base*. [Basic Science / Preclinical]
Xue E (2026). [PMID: 41221671](https://pubmed.ncbi.nlm.nih.gov/41221671/). *Head Neck*. [Clinical Trial Publication]
Bayraktar FGİ (2026). [PMID: 41190732](https://pubmed.ncbi.nlm.nih.gov/41190732/). *Laryngoscope*. [Review / Meta-Analysis]
Chen SF (2026). [PMID: 41467362](https://pubmed.ncbi.nlm.nih.gov/41467362/). *Head Neck*. [Clinical Trial Publication]
AI-curated news mentioning nasal cavity olfactory neuroblastoma
Updated May 28, 2026
A recent study published in PubMed examines clinical outcomes and failure patterns following postoperative intensity-modulated radiation therapy (IMRT) for olfactory neuroblastoma. The findings highlight late cervical nodal relapse as a significant concern in patient management.
A recent study published in PubMed examines outcomes following en bloc resection of olfactory neuroblastoma, providing insights into surgical efficacy and patient prognosis. This research contributes to the understanding of treatment options for this rare cancer.
A recent study published in PubMed explores the detection of DNA viruses in olfactory neuroblastomas using targeted enrichment next-generation sequencing. This research could enhance understanding of the viral involvement in this rare tumor type.